Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Survival Analysis and the Effect of Censoring for Lung Cancer

Principal Investigator
Name
Azar Shahraz
Degrees
Ph.D.
Institution
AstraZeneca
Position Title
Associate Director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-991
Initial CDAS Request Approval
Jul 22, 2022
Title
Survival Analysis and the Effect of Censoring for Lung Cancer
Summary
The aim of this project is to study the effect of censoring in survival analysis in oncology clinical trial.
We want to investigate the best parametric/semi parametric models for survival analysis and study the effect of censoring on each type.
Aims

The aim of this project is to study the effect of censoring in survival analysis in oncology clinical trial.

Collaborators

No collaborator.